“Topical CBD products are excellent for the management of aches and pains that can prevent you from doing chores and living the lifestyle you desire.” Learn More
“Jessica Tonani, CEO of Verda Bio, a bio-tech company that has sequenced the cannabis genome and is performing cutting edge research, feels part of a nascent market.“ Learn More
“I think the definition of chronic pain can be very different,” says Jessica Tonani, co-founder of Basic Jane, the only cannabis company in the U.S. that holds a license to research CBD." Learn More
“Basic Jane the first consumer-focused line of products from research company Verda Bio, which was founded by scientists with the mission to discover, develop and bring novel cannabinoid-based remedies to market…” Learn More
“Another consideration is the topical you’re using. There are so many different types of CBD topicals, but they aren’t all equally effective.” Learn More
“Dozens of smaller companies, are also developing hemp/cannabis drugs or patentable synthetic cannabinoids. One of the most promising is Seattle-based Verda Bio…” Learn More
“Verda Bio plans to perform research into the genetics of marijuana plants and test the 85 known cannabinoids for their variable concentrations and efficacies across different strains.” Learn More
“That brings us to the first company with a government license to actually breed and analyze cannabis…” Learn More
“For instance, Washington State-based Verda Bio is developing a DNA database to enable growers to create varieties with consistent levels of cannabinoids.” Learn More
“The research that needs to be done on this plant isn’t reinventing the wheel; it’s just doing what we need to do,” said Tonani, who also co-founded Basic Jane.” Learn More
“This brainy powerhouse is the co-founder of Verda Bio (a cutting-edge bio-tech company sequencing the cannabis genome) and Basic Jane (a line of plant-based topicals and essential oils) — two amazing brands that help in the science world, as well as the wellness industry.” Learn More
“The end goal is to create strains optimized for specific medical conditions, like anxiety, cancer or pain.” Learn More
"You don't want a 6-year-old with epilepsy being put on a bus under the influence of a psychedelic chemical," Tonani told The Seattle Times. No, you do not.” Learn More
5 Profiles of interesting people in the pot world: Tonani formed Verda Bio, a company devoted to researching the genetics and therapeutic uses of marijuana. Learn More
“Tonani, who has lobbied for years to create a state marijuana research license, is looking to selectively breed marijuana plants based on the cannabinoids they contain…” Learn More
“Research findings show that not all cannabis is the same. In fact, according to the Seattle biotech firm Verda Bio, there are more than 85 identified cannabinoids known to target receptors throughout the body." Learn More
“Verda Bio, a Seattle-based pharmaceutical company, said they successfully received their research license and will soon be growing cannabis in their SoDo facility.” Learn More
“Chief Executive Jessica Tonani says Verda intends to breed cannabis plants to emphasize compounds that currently exist only at low levels, so that those compounds can then be studied for potential therapeutic uses.” Learn More
“The reality is that pretty basic research needs to be done," said Jessica Tonani, CEO of Verda Bio, a Seattle company that is seeking a permit from the state to research cannabis.” Learn More
“The Washington Liquor and Cannabis Board says it has issued the state's first license to grow marijuana for research.” Learn More
“To address that question, Verda Bio plans to begin by selectively breeding cannabis plants for specific compounds in cannabis, including less common cannabinoids such as THCV, CBDV, CBG, and CBC.” Learn More
“Verda Bio, is to build a database bringing order to billions of potential DNA combinations and, eventually, create stable strains that people can grow like a Red Delicious apple.” Learn More
